Diasorin SpA (WBO:DIAS) Accounts Payable : €100 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Diasorin SpA Accounts Payable?

Diasorin SpA's Accounts Payable for the quarter that ended in Dec. 2024 was €100 Mil.

Diasorin SpA's quarterly Accounts Payable declined from Jun. 2024 (€99 Mil) to Sep. 2024 (€0 Mil) but then increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€100 Mil).

Diasorin SpA's annual Accounts Payable declined from Dec. 2022 (€104 Mil) to Dec. 2023 (€101 Mil) and declined from Dec. 2023 (€101 Mil) to Dec. 2024 (€100 Mil).

Diasorin SpA Accounts Payable Historical Data

The historical data trend for Diasorin SpA's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Accounts Payable Chart

Diasorin SpA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

65.49

84.77

104.20

100.71

99.52

Diasorin SpA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable	Get a 7-Day Free Trial															100.71	-	98.67	-	99.52

Diasorin SpA Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Diasorin SpA Accounts Payable Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (WBO:DIAS) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

DSRLF:USA DIA:Italy DIAm:UK 0GZX:UK 34D:Germany

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines